Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE IN PLASTIC CONTAINER.
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium chloride dissociates to potassium ions, which are essential for maintaining intracellular osmolarity, transmembrane electrochemical gradients, and normal neuromuscular excitability. Dextrose 5% provides a source of calories and may help shift potassium intracellularly via insulin secretion.
Potassium chloride dissociates to potassium ions, which are essential for maintenance of intracellular tonicity, nerve impulse conduction, muscle contraction, and cardiac function.
40 mEq intravenously over 2-4 hours, not to exceed 10 mEq/hour or 200 mEq/day; requires continuous ECG monitoring.
10-20 mEq intravenously over 1 hour, not exceeding 10 mEq/hour or 200 mEq per day; oral dosing for hypokalemia: 20-40 mEq 2-4 times daily.
None Documented
None Documented
Not applicable; potassium is not eliminated by first-order kinetics; distribution half-life is approximately 1 hour, with terminal elimination dependent on renal function.
No classical terminal half-life; plasma potassium is rapidly regulated by cellular uptake and renal excretion, with equilibration half-life of ~1-2 hours in normal renal function.
Renal: >90% of potassium is excreted by the kidneys, primarily via distal tubular secretion; fecal and sweat losses account for <10%.
Primarily renal (90% excreted unchanged in urine); minor fecal elimination (<10%) via unabsorbed potassium.
Category C
Category C
Electrolyte Replenisher
Electrolyte Replenisher